4SC
Pre-clinicalOur products shall provide patients with innovative treatment options being more tolerable and efficacious than existing ones for a better quality of life.
Founded
1997
Focus
Small Molecules
About
Our products shall provide patients with innovative treatment options being more tolerable and efficacious than existing ones for a better quality of life.
Funding History
3Total raised: $37M
Debt$5MUndisclosedApr 15, 2022
Series B$20MUndisclosedNov 15, 2020
Series A$12MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded1997
LocationPlanegg, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile